Scalper1 News
Anglo-Irish drugmaker Shire (SHPG) announced on Monday that it had agreed to acquire NPS Pharmaceuticals for $5.2 billion in an all-cash deal. Dublin-based Shire said on Sunday that it will pay $46 a share for NPS Pharmaceuticals (NPSP), which is based in New Jersey and specializes in drugs for gastrointestinal disorders. That represents a 51% premium to NPS Pharmaceuticals share price of 30.47 on Dec. 16, before rumors of the deal emerged. The Scalper1 News
Scalper1 News